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Summary 
Title: THE EVER GROWING COMPLEXITY OF TROPHOBLAST EPIGENETICS 
 
Author: Katharina Alexandra Schmidt 
 
Mammalian placentation is closely regulated by the actions of trophoblast cells at the time of 
implantation. Invasion of trophoblast into uterine tissue is an essential process in placentation 
and appropriate fetal development. Since human trophoblast is responsible for appropriate fetal 
growth, it is of major interest in the field of medicine, particularly in understanding how it is 
influenced by different processes and environmental conditions.  
This review is sought to give an insight into the complexity of trophoblast epigenetics and 
different processes and environmental factors controlling it. 
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Naslov: RA TUĆA  LOŢENO T EPIGENETIKE TROFOBLASTA 
 
Autor: Katharina Alexandra Schmidt 
 
Proces implatacije u sisavaca precizno je reguliran djelovanjem stanica trofoblasta tijekom 
implantacije odnosno njegovom invazijom u sluznicu maternice što je preduvjet razvoja zdrave 
posteljice i djeteta. Ovakvo invazivno ponašanje trofoblasta, posljedično najviše utjeće na 
usklađeni rast djeteta, stoga postaje predmet brojih istraţivanja na polju medicine s posebnim 
osvrtom na utjecaj i uvjete okoline.  U ovom preglednom radu, nastojali smo dati uvid u 
sloţenost epigenetskih procesa u stanicama trofoblasta te različitih faktora koji ga kontroliraju. 
 
Ključne riječi: epigenetika, trofoblast, razvoj, placenta, majčin okoliš 
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1. Introduction 
 The field of epigenetics is a rapidly expanding field of contemporary biology, with a 
significant impact on modern biological processes and therefore of major importance in the field 
of medicine. [1]. Epigenetics refers to any DNA sequence-independent alteration in the 
expression of genes and organization of chromatin. [1]. Epigenetics plays a significant role in the 
functioning of the genome in adults and during development [2], and as such, has attracted 
significant research interest over the past years. The significant influence of epigenetics has been 
felt in various fields of contemporary medicine, including placentology, where gene-expression-
regulating epigenetic mechanisms have demonstrated a significant influence on gene regulation, 
as it is evident in the placentation and implantation of trophoblast cells. [3]. The gene regulation 
associated with epigenetics occurs in various ways, and at different molecular levels. DNA 
methylation is one of the most frequently researched gene regulations associated with epigenetic 
mechanisms. [3]. This paper examines the ever-growing complexity of trophoblast epigenetics. 
Particularly, the paper explores the background of epigenetics, the concepts of DNA 
methylation, histone modification (acetylation, methylation, ribosylation), and non-coding 
RNAs. In addition, the paper provides a brief overview about trophoblast development and of the 
main regulatory pathways.  
Epigenetic changes of trophoblast in maternal obesity and diabetes are also examined. 
Furthermore, effects of environmental stressors are explored, as well as effects of maternal diet 
on trophoblast development.  
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2. Epigenetics Background 
 The term ―epigenetic‖ simply refers to ―in addition to changes in genetic sequence.‖ [4]. 
Epigenetics has undergone evolution to encompass any process that entails the alteration of gene 
activity without altering the DNA sequence and can be transmitted to daughter cells. [4]. While 
epigenetic processes are natural and important to the development and functioning of most 
organisms, major adverse effects can be seen if they occur improperly.  
Epigenetics, just like most of the contemporary scientific discoveries, traces its origin from the 
1930s, when Conrad Waddington first used the term epigenome to describe the developmental 
process through which an organism’s phenotype is produced by its genotype. [5]. In 1943, 
Waddington wrote a seminal paper in which he explained the complex processes involving 
multiple development-controlling genes. [5]. However, in that seminal paper, Waddington 
provided no account of the influence of environmental modifiers on gene expression. [6]. The 
joint work of Jablonka and Lamm [7] attempted to demonstrate a specific new meaning of 
epigenetics. Jablonka and Lamm are credited for having given epigenetic its first specific 
definition as the biological mechanisms that give rise to persistent developmental alterations in 
the activities and effects of genes, without altering DNA sequences from one generation to 
another. [5].  
 It was  cott Gilbert’s [9] work, contextualizing Waddington’s ideas of epigenetics, which 
brought a paradigm shift to the responsibility of genes in influencing the mechanics of 
development. [5]. Since the enlightening work of this great scientist, the epigenetics landscape 
has undergone enormous development. Some of the mechanisms associated with the 
understanding of the processes associated with epigenetic changes include DNA methylation, 
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histone modification, as well as changes in the chromatin structure as a result of non-coding 
RNA activity and chromatin re-modelling. [10].  
Recently, a strong link between epigenetic regulation and placental development has been 
established and it is clear that epigenetic regulators, and associated transcription factors, play a 
critical role in maintaining a healthy pregnancy. [43]. 
Continued research in the field of epigenetics has been promising, especially in terms of 
developing novel treatment methods for a wide range of human diseases, most importantly 
tumorigenesis.  
 
2.1. DNA Methylation 
 DNA methylation is the best understood epigenetic process and is considered a classical 
example of epigenetic activity of gene expression during development. The scientific importance 
of DNA methylation as an epigenetic process and the reason why it is best known, comes mainly 
from its ease to be studied using nowadays available technologies. [4]. DNA methylation mostly 
takes place in areas with consecutive occurrence of cytosine bases, where a methyl group (CH3) 
is added or removed. [4]. The occurrence of DNA methylation was first reported in 1983 
associated with human cancer and since then its importance has been recognized in a wide range 
of human disease. [4].  
 DNA methylation is a stable epigenetic process that can be inherited from one generation 
to another through multiple cell divisions and it is very dynamic during the process of 
mammalian development, maintenance of cellular identity and cell differentiation. [11]. 
According to Kim and Costello [11,12], the profiles of DNA methylation can play a critical role 
in classifying lineages as well as controlling the quality of stem cells, such as mesenchymal stem 
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cells and embryonic stem cells. This is possible because DNA methylation can reflect the 
original tissue even after a long-term culture. [13,14].  
 In vertebrates, DNA methylation is confined to the CpG sites. [11]. However, the presence of 
non-CpG methylation has been reported in pluripotent stem cells. [15,16]. It is estimated that of 
the twenty-nine million CpG sites that exist in the human genome, between 60% and 80% of 
them are methylated. [17]. The CpG islands (CGIs), which are characterized by high CpG 
density, are made up of an estimated 7% of CpG sites. [18]. While CGIs are predominantly 
resistant to DNA methylation, about 70% of annotated gene promoters are linked to CGIs. [19]. 
The activity of DNA methylation is accomplished by DNA methyltransferases (DNMTS), which 
include the main enzymes: DNMT1, DNMT3A, DNMT3B, and DNMT3C [20,21].  
 Despite the critical role that DNA methylation plays in mammalian development and in 
disease progression, it remains uncertain whether DNA methylation has a direct function at 
specific sites. [11]. However, some of the existing technological developments for editing DNA 
methylation are expected to play an important role in determining site-specific functions of DNA 
methylation. [25-29]. The role of DNA methylation in identifying the cell of origin is essential in 
cancer research and in cellular biology. DNA methylation profiles are expected to play a critical 
role in the medical field, in terms of developing patient type-specific treatment, tumor-type-
specific treatment, as well as in regenerative medicine. [11].  
 
2.2. Histone Modification 
Histone modifications occur post-transcriptionally, influencing the transcription, as well 
as repair mechanisms of the DNA.  
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The genetic potential of DNA is influenced by various epigenetic modifications of histones, like 
acetylation, methylation, ADP ribosylation, phosphorylation and ubiquitination. [30]. Various 
epigenetic markers present in the genome demonstrate the significant potential of histone 
modification. [30]. Epigenetics entails heritable changes in the phenotype which do not cause 
alterations in the base DNA sequence, and histone modifications are therefore epigenetic 
regulators of chromatin.  
High-order chromatin structure is influenced by the histone code, which determines the contacts 
between DNA and histones, and between the different histone molecules. [30]. The 
compartmentalization of the genome into various distinct domains (e.g., transcriptionally active 
euchromatin and transcriptionally silent heterochromatin) is due to various specific states of 
histone modification. [31]. The histone code’s ability to control the chromatin environment 
therefore gives it regulatory power over different nuclear processes such as transcription, DNA 
repair, replication, as well as chromosome condensation. [32].  
 Besides DNA methylation, histone methylation and histone acetylation are the two other 
well-explored epigenetic processes. [30]. Epigenetic modifications such as histone modifications, 
and related nuclear distributions undergo specific alterations during different cellular processes. 
One of the milestones in cellular biology has been the identification of the various enzymes that 
initiate epigenetic processes, including histone modification. [33]. The identification of the 
epigenetic process-initiating enzymes has made it possible to investigate various aspects of 
epigenetic regulation. [30]. The advancements made in epigenetics research so far has been 
promising, and the translation of the histone code is expected to lead to more discoveries in 
related biological processes and disease states. [30]. The knowledge about the influence of 
epigenetics on genomic reprogramming in the course of embryonic development is expected to 
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revolutionize the field of regenerative medicine in terms of facilitating the development of novel 
therapeutic approaches. [34]. In addition, inhibitors of DNMTs and HDACs have demonstrated 
enormous potential in cancer treatment. [35].  
 The treatment potential of histone modification has been investigated and reported in 
various studies. For example, Gavin and Sharma [36] found that modification of the chromatin 
structure can be a factor in treatment response to schizophrenia. According to their paper [36], 
histone modification offers an opportunity to develop novel medication for the treatment of 
schizophrenia.  
 DNA methylation and histone modification play a critical role in the establishment of 
patterns of genomic repression during development of mammals. [37]. While certain forms of 
histone methylation lead to the formation of reversible heterochromatin, DNA methylation on 
the other hand is associated with stable long-term culture repression. [37]. The modification 
pathways associated with DNA methylation and histone modification provide an interdependent 
relationship, which can be mediated by biochemical interactions between DNA 
methyltransferases and histone methyltransferases. [37]. A study by Cedar and Bergman [37] has 
found that DNA methylation-histone methylation interrelationships can facilitate the 
understanding of normal development in mammals as well as tumorigenesis and reprogramming 
of somatic cell.  
 
2.3. Non-Coding RNAs 
 Non-coding RNAs (ncRNAs) are all RNA molecules that are not translated into proteins 
after transcription of the genome. Today we know that more than 60% of the genome are 
transcribed into ncRNAs and that they play a critical role in the regulation of the human 
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genome’s epigenetic status. [38]. In addition to their involvement in normal physiology, non-
coding RNAs are also associated with a wide range of human diseases, including cancer. [38]. 
According to Morlando and Fatica [38], non-coding RNAs’ interaction with epigenetic 
regulators, their ability to control chromatin topology, as well as their mis regulation, can lead to 
an aberrant regulation of gene expression, which may act as a contributing factor to 
tumorigenesis. Since their introduction into the field of epigenetics, thousands of ncRNAs have 
been identified, and they are for example found to have a direct association with cardiovascular 
pathologies. [39]. Different classes of ncRNAs with various functions exist. The common 
ncRNAs and their respective functions are summarised in table 1. 
 
Table 1: Classes and Functions of RNAs. [39] 
Classes of 
ncRNAs 
Examples of ncRNAs Symbols of 
ncRNAs 
Description of Functions 
Short-ncRNAs microRNA miRNA Posttranscriptional regulators 
Piwi-interacting RNA piRNA DNA methylation and transposon 
regression 
Short-interfering RNA siRNA RNA interference 
Long-ncRNAs Long-intervening 
ncRNA 
lincRNA Serve as transcription epigenetic 
regulators.  
Small nucleolar RNA snoRNA Facilitation of nucleotide 
modification. 
Circular RNA circRNA miRNA sponging and RNA 
polymerase II regulators 
 
  According to Blignaut [40], the simplified molecular biological dogma, which 
involves the genetic encoding for protein via mRNA, remains the core of genetics. However, the 
genomic region that was previously referred to as ―junk‖ DNA has subjected that sequence of 
events to an extremely complex web of regulation. [40]. Blignaut [40] found that ncRNAs are 
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not only intricately engulfed by, but also play an active role in influencing the epigenetic 
processes, such as those that occur during tumorigenesis, in vascular pathologies and in a broad 
spectrum of other human diseases.  
 
3. Trophoblast Development 
Trophoblasts are specialized cells of the placenta and play an important role in implantation and 
placentation. [41].  
Trophoblast development begins a few days after fertilization occurs at the blastocyst stage. The 
transition from morula to blastocyst is marked by the appearance of a fluid-filled inner cavity 
and is characterized by cellular differentiation, which gives rise to the embryo (i.e., the inner 
cells) and the trophoblast (i.e., the surface cells). [41]. The trophoblast is able to proliferate and 
invade the mother’s tissue rapidly, a characteristic shared with malignant cancer cells, but 
fortunately the processes occurring in the first days of a pregnancy are highly regulated and 
controlled. After 72 hours upon entering the uterine cavity, the embryo hatches and exposes its 
outer covering of trophectoderm. [41].  
 The trophoblast not only plays the physical role of linking the fetus to the mother but also 
facilitates the alteration of the vasculature in the uterus to allow the provision of adequate blood 
supply to the fetus. [41].  
Implantation of the embryo is highly dependent on differentiation of the trophoblast lineage, 
which is first evident during the morula stage. [41]. 
In a way, the development of an embryo can be described as a sequence of controlled epigenetic 
changes in DNA-methylation patterns over the course of a pregnancy. 
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 Significant influence of epigenetics is observable in a wide range of contemporary 
medicine, including placentology, in which gene expression-regulating epigenetic mechanisms 
influence trophoblast implantation as well as placentation. [43]. Epigenetic processes such as 
DNA methylation play a significant regulatory role in trophoblast implantation and placentation. 
[43]. In their review, Serman and Dodig [3] demonstrated how alterations in gene methylation 
can affect trophoblast development and placentation, and thus suggested the potential of 
trophoblast epigenetics in understating cancer cell invasion and growth. Trophoblast cells not 
only share their high proliferative rate with malignant cancer cells, but also their loss of contact 
inhibition, migration and invasion, as well as their ability to control telomerase and tissue 
vascularization. [66]. 
 The appropriate establishment and organogenesis of the placenta is critical for normal fetal 
growth and mammalian development. [43]. Proper placental functioning is dependent on 
syncytiotrophoblast (STB) formation and the invasion of the endometrium by trophoblast cells. 
[43]. Trophoblast migration and endometrial invasion are akin to tumor metastasis, as they are 
both characterized by similar molecular mechanisms. [43] However, contrary to the scenario in 
cancer cells, the initiation of trophoblast migration and endometrial invasion are firmly regulated 
by a feto-maternal cross-talk, which if not functioning physiologically, can lead to various 
abnormalities. [43]. The trophoblast is controlled by a range of factors, including hormones and 
cytokines, and these regulating factors are influenced by transcriptional regulatory networks. 
[43] 
 Research has shown that the trophoblast invasiveness is regulated by a complex interplay 
of various stem cells, as well as signaling pathways. [44]. A number of studies have found 
haemochorial placentation similarities in humans and rats [44-47]. In this regard, most studies 
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have used rats as model animals to investigate trophoblast lineage invasiveness. [44]. 
Consequently, many signaling pathways regulating the differentiation and invasiveness of 
trophoblast cells have been identified, investigated, and reported about in various studies. Some 
of the important signaling pathways include: mTOR signaling pathway, IGF-2 signaling 
pathway, and Hedgehog signaling pathway.  
 
3.1 mTOR Signaling Pathway 
 Mammalian target of rapamycin (mTOR) has been reported to have a significant 
regulatory effect on trophoblast differentiation and endometrial invasion. [48].  
One example of its importance is the regulation of folate transport in pregnancies, required for 
methylation reactions, DNA repair and de novo DNA synthesis. [48]. 
Even though we know that the fetus depends entirely on placental transfer of folate and that the 
lack of it has devastating effects on the development of an embryo, like structural malformations 
and intrauterine growth restriction, the molecular mechanisms that are responsible for the 
placental folate transportation remain unknown.  
Using human trophoblast cells, the hypothesis that mTORC1 and mTORC2 are regulators of 
placental folate transportation, has been tested. [48]. The results show that both, mTORC1 and 
mTORC2 are significant positive regulators of the placental folate transportation. According to 
[48], mTOR’s signaling regulation of the placental folate transportation provides a direct link 
between the functions of placenta, fetal programming, and gene methylation. As mentioned 
above, fetal development and growth depends on the mother’s folate availability and by 
regulating its transport, mTORC1 and 2 signaling could be a very important connection between 
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maternal nutrition and fetal growth. [48]. mTOR is believed to serve as a nutrient sensor, having 
the ability to be regulated by growth factor signaling in multicellular organisms. [49]. 
Another important function of mTOR was researched by Wen [49] who investigated trophoblast 
cell proliferation in reaction to angiopoietin-2 (Ang-2), which is specifically expressed in the 
placenta. Here, the mTOR signaling pathway was used to induce trophoblast proliferation. The 
ultimate finding of this study shows the importance of mTOR in regulating trophoblast cell 
proliferation as well as endometrial invasion and therefore, it is essential in determining the 
success of every pregnancy. [49].  
 
3.2. IGF-2 Signaling Pathway 
 Insulin-like growth factors 2 (IGF-2) enhances human first-trimester cytotrophoblast 
(CTB) proliferation and survival by signaling via the insulin-like growth factor 1 receptor 
(IGF1R). [50]. Phenotypic characterization of IGF-2 null mice established the potential of IGF-2 
in regulating placentation, as well as fetal and postnatal mammalian growth. [51]. For instance, 
Harris [50] investigated trophoblast proliferation and survival in response to IGF-2 signaling. 
The findings indicated that IGF-2 had a regulatory effect on trophoblast proliferation and 
endometrial invasion. In another study that came to a similar conclusion, Chen [52] investigated 
the effect of IGF-2 on the proliferation of human trophoblast in vitro. Ultimately, the results 
established that IGF-2 enhances extra villous cytotrophoblasts (EVCTs) proliferation and also 
inhibits apoptosis. [52]. The study concluded that the IGF-2 is an important signaling pathway 
for regulating the proliferation of trophoblasts during the early stages of human pregnancy in 
vitro, therefore indicating the significance of the IGF-2 signaling pathway in regulating 
trophoblast proliferation and endometrial invasion in every pregnancy. [52]. 
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3.3. Hedgehog Signaling Pathway 
 The hedgehog proteins, namely Sonic hedgehog, Indian hedgehog and Desert hedgehog, 
have specific roles in various processes of organogenesis in humans. [53].  
Cell-to-cell fusion in the placenta to form STBs - syncytialization - plays a critical role in 
ensuring normal development and efficient functioning of the human placenta. [53]. Hedgehog 
signaling proteins are largely expressed in the human placental villi. [53]. In this regard, Tang et 
al. investigated the potential of Hedgehog signaling pathway in regulating trophoblast fusion and 
its need for synthesis of human placental hormones. The study established that Hedgehog/GLI2 
(glioma-associated oncogene) had a significant signaling-influence in inducing syncytialization 
and trophoblast fusion. Based on these results, it can be concluded that Hedgehog signaling, 
through GLI2, plays a critical role in enhancing mammalian placental development, as well as in 
pregnancy maintenance. [53].  
In another study, Lu [54] hypothesized that Estrogen-related receptor β could enhance the 
modulation of the Hedgehog signaling pathway and consequently affect Hedgehog-driven gene 
expression. The findings of that study indicated that Hedgehog signaling has a significant impact 
on several Hedgehog-responsive mRNAs, including Hoxd8, and Hsd11b1. [54]. The results 
indicate the significance of the Hedgehog signaling pathway in regulating trophoblast 
proliferation and endometrial invasion. 
Hedgehog proteins play a vital role in cell growth, cell survival and cell fate decision, being one 
of the most important intracellular signals, especially regarding implantation and successful 
placental maintenance. [53]. 
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 IGF-2, mTOR, and Hedgehog serve as important signaling pathways, all essential for 
healthy development of an embryo, mainly by regulating trophoblast proliferation and invasion 
of the endometrium. 
4. Epigenetic Changes of Trophoblast in Maternal Obesity 
 Obesity is a major health problem in the developed world, affecting more and more 
adults and an increasing number of children. Women of reproductive age are increasingly 
overweight (BMI = 25-30 kg/m2) or obese (BMI > 30kg/m2); consequently, the number of obese 
pregnant women is increasing as well. [55]. Both maternal obesity and excessive gestational 
weight gain cause an adverse intrauterine environment and are a major risk contributor for 
developing metabolic diseases, but also program the fetus in ways that may become apparent 
later in life. [55]. An obese maternal environment is characterized by hyperlipidemia and chronic 
state of inflammation, as well as increased oxidative stress, compared to a normal pregnancy. 
[69]. 
 
 
Figure 1: Mechanisms linking maternal obesity to placental dysfunction and developmental 
programming. [64]. 
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Pregnancy is a state of profound metabolic changes; maternal obesity strongly contributes to an 
adverse intrauterine environment and is often linked to an impaired metabolic status of the 
offspring and the mother. [56]. The effects of an adverse maternal environment are transmitted to 
the fetus via the placenta. According to Hirschmugl, the adverse effects of impaired metabolic 
functions are often attributed to epigenetic changes in utero. However, the associations between 
these adverse effects and in utero epigenetic changes are insufficiently understood. Due to the 
uncertainties and lack of clear-cut evidence on the linkage between maternal obesity and the 
impaired metabolic status of the offspring and mother, Hirschmugl [56] studied 73 lean and 
obese mothers with healthy pregnancies. The study measured certain metabolic parameters (e.g., 
gene expression, gene protein quantification) from the recruited women’s maternal venous blood 
samples, which were then correlated with maternal parameters and immunolocalized in placental 
segments. [56]. The results showed that triglyceride (TG) content in the placental tissues of lean 
participants were much lower than in obese participants. [56]. In addition, among examined 
genes, six exhibited a significant positive correlation (P < 0.05) with maternal pre-pregnancy 
BMI. Protein content was also found to be higher (p < 0.001) in placentas of obese participants 
compared to lean participants and a positive correlation was established between CGI-58 protein 
levels and maternal insulin levels, adversely causing hypoglycemia in the fetus in utero and 
contributing to development of insulin resistance later in life. [56].  
 Accordingly, [56] suggested that the up-regulation of CGI-58, which was identified as a 
master regulator of TG hydrolysis, causes the turnover of intracellular lipids in the placenta of 
obese women. CGI-58 is tightly regulated by the mother’s metabolic factors and, therefore, it can 
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be concluded that maternal obesity is responsible for the modulation of the expression of lipid-
related genes within the human placenta. [56]. 
 Panchenko [57] highlighted that the epigenetic machinery and gene expression, 
particularly the histone acetylation pathway, is highly sensitive to maternal obesity. The 
transcriptional changes induced by maternal obesity can cause alterations in the placenta as well 
as in the hepatic epigenome, and cause fetal growth restriction (FGR), particularly in obese 
women. [57]. According to Panchenko, pre-conceptional weight loss is necessary for ensuring 
proper fetal growth, but certain effects of pre-pregnancy obesity can still be retained in the 
offspring’s phenotype. [57].  
The existence of chronic low-grade inflammation in obese women leads to an inflammatory in 
utero environment and therefore adverse outcomes for the physiologic development of the 
embryo. [64]. 
 
5. Epigenetic Changes of Trophoblast in Maternal Diabetes   
Diabetes is not only an increasingly present problem in nowadays society, the number of 
pregnancies accompanied by gestational diabetes mellitus (GDM) is increasing as well. In 
developed countries approximately every 10
th
 pregnancy is complicated by GDM and many of 
them remain unrecognized and therefore untreated, partly due to a lack of universal screening 
programs. [65].  
Due to an increased need for food supply to the fetus in the late trimester, the mother can 
develop a moderate peripheral insulin resistance, creating a diabetogenic situation. The resulting 
intrauterine hyperglycemia not only leads to an increase in perinatal morbidity/mortality but also 
poses the risk of exposing the offspring to the development of chronic diseases later in life. [58]. 
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Over- and under-nutrition can lead to persistent epigenetic changes in the offspring’s genome. 
These changes consequently influence metabolism, neuroendocrine functions and energy 
homeostasis. [58]. According to [58], the success of a pregnancy is determined not only 
determined primarily by the outcome at birth, but also by the status of postnatal health.  
 Haertle et al. showed that intrauterine exposure to GDM leads to epigenetic modifications 
and poses a chronic risk of complex disorders to the offspring. [59]. They conducted a genome-
wide comparison of methylation patterns of fetal cord blood (FCBs) taken from mothers with 
GDM with those from mothers without GDM. The study found that the effects of GDM on FCB 
methylation were predominant in women who presented with insulin-dependent GDM, and who 
had been diagnosed with more severe metabolic phenotypes. [59]. However, and according to the 
findings of the study, FCB methylation of women who presented with dietetically treatable GDM 
was less affected. [59].  
 The findings show a clear correlation between maternal diabetes, particularly GDM, and 
epigenetic changes in the trophoblast. Despite the observable small effect size associated with 
the FCB methylation, the effect of FCB methylation on genes is significant and detrimental to 
the exposed offspring. [59]. According to Haertle et al. the identified genes act as primary 
vehicles for transmitting the effects of GDM to the succeeding generation. Even though the 
mechanisms responsible for long-term morbidity risk in the offspring are still poorly researched 
and understood, epigenetics is thought to be a key player in the process. [59] 
In addition, the genes may act as sources of essential biomarkers for diagnosis, prognosis and 
treatment of harmful prenatal conditions. [59]  
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6. Effects of Environmental Stressors on Trophoblast Epigenome  
 The identification of the impact of environmental stressors on human health lies at the 
core of life sciences and biomedical research. [60]. The recognition that exposure to adverse 
environmental conditions could lead to DNA mutations forms the idea of environmental risk 
assessment and prevention. [60]. The human placenta and its various functions play a critical role 
in ensuring healthy and desirable reproductive outcome. [61]. According to Robins [61], the 
environment within a pregnant woman lives in or is exposed to can impact and influence the 
placental functions. Some environmental stressors can lead to the alteration of the appropriate 
genetic programming necessary for a sustainable pregnancy and normal, healthy fetal 
development. [61]. 
 The alteration of genetic programming can be caused by environment-exposure-related 
epigenetic alterations. [61]. Research continues to link epigenetic alterations not only to 
successful pregnancies, but also to other significant reproductive outcomes. [61]. Some of the 
reproductive outcomes that can result from environmental exposures include early stage 
pregnancy loss, congenital syndromes (such as Beckwith-Wiedemann syndrome), IUGR, as well 
as preeclampsia and pre-term birth. [61].  
 Trophoblast cells are responsible for connecting the embryo to the human uterus and 
serve as interface between the fetus and the mother. The hormonal mechanisms associated with 
trophoblast activity are influenced by physiologic alterations associated with pregnancy, most of 
which are dependent on the status of the pregnancy. [61]. Therefore, to ensure a successful 
maintenance of the pregnancy it is fundamental to ensure normal trophoblast development.  
Factors that can interfere with normal trophoblast development are for example endocrine 
disruptors, such as xenoestrogens and antiandrogenes, and even altered intrauterine oxygen 
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levels can play a critical role. [61]. This can be further explained on the example of BPA. BPA is 
one of the xenoestrogens and the exposure risk today is widely connected to use of plastic 
bottles, where especially when heated up, the chemicals leach into the content of the bottles. 
BPA’s toxicity and endocrine disruption is mainly due to its binding to estrogen receptors, thus 
interfering with endogenous estrogen, and leading to disruptions of the reproductive system, 
brain and behavior. [68].  
In a survey from 2004, BPA could be detected in more than 95% of Americans over the age of 
six. [61].  
 
 
 
 
Figure 2: Model of appropriate epigenetic programming throughout gestation and the potential  
 
epigenetic effects of environmental factors and their downstream consequences. [61]. 
 
This implies that monitoring and preventing environmental hazards, like BPA, to which a 
pregnant woman is exposed, are the key components in maintaining a healthy and successful 
pregnancy. 
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7. Effects of Maternal Diet on Trophoblast Development 
 Maternal nutrition plays a major role in fetal and placental development, partly by 
providing the necessary nutrients for successful growth of the fetus’s genomic structure and 
function and also by its impact on the placenta and its ability to support the fetus with required 
conditions for a successful development. The behaviour of trophoblast cells during the time of 
implantation has a significant influence on mammalian placentation. [62]. Appropriate fetal 
growth and development is greatly influenced by the maternal nutrition the offspring is exposed 
to. [62]. In recent years, regulation of fetal growth and development has been increasingly 
interesting for epidemiological and human observational models, to show a link between 
adversely changed fetal growth and predispositions to cardiovascular and metabolic disease later 
in life. [62]. Thanks to the significant similarities between rodent and human preimplantation 
embryo development, implantation and placental morphology, it hast been possible to use mice 
and rats as biologically applicable models in researching the effects of maternal diet on 
developing placenta, as well as on fetal and child development and health. [62].  
A study conducted by Watkins using a mouse maternal diet, as representative of a human 
maternal diet, found that a mouse maternal diet that is low in calories decreased the growth of the 
offspring and leads to genome-wide hypomethylation, whereas a diet high in fat induced 
placental gene expression changes that regulate epigenetic modifications and predisposed the 
offspring to adult metabolic and cardiovascular conditions. Decreasing a diets protein contents in 
rodents lead to apoptosis, growth inhibition and epigenetic modification, especially effecting 
mTORC1. In contrast, if fed with high protein diet exclusively during preimplantation, mice 
displayed enhanced postnatal growth and adiposity, as well as hypertension and vascular 
dysfunctions in adult offspring. [62]. According to Watkins et al. enhanced early postnatal 
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growth was found out to be a significant predictor of adiposity, cardiovascular disease and 
behavioral changes in adults. They also found that trophoblast was capable of modifying its 
growth and phenotype for purpose of regulating and ensuring proper growth of the fetus in cases 
of poor maternal nutrition. However, as mentioned above, these adaptive mechanisms will 
become maladaptive if the changes persist for too long and eventually predispose offspring to 
adult-onset disease. [62].  
 Therefore, unfavorable maternal diet can expose the fetus to a wide range of diseases, 
including hypertension, obesity, and metabolic syndrome. [63]. Kappen et al. demonstrated that 
pregnancy-specific diets are detrimental to the health and well-being of the offspring.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 27 
Conclusion 
This review seeks to develop an understanding of the ever-growing complexity of trophoblast 
epigenetics. Continued research in the field of epigenetics has been promising, in terms of 
understanding a wide range of human disease and more importantly developing novel treatment 
methods. The significant influence of epigenetics is evident in human placentology, where it has 
been found that gene expression-regulating epigenetic mechanisms influence trophoblast 
implantation and placentation and, therefore, determine the success of a pregnancy. Three main 
regulators of epigenetic mechanisms - non-coding RNAs, DNA methylation, and histone 
modification - have proven to be of importance in understanding the beginning of life, as well as 
regenerative medicine and various other domains of science.  
The trophoblast not only plays the physical role of linking the fetus to the mother but also 
facilitates the alteration of vasculature in the uterus to allow the provision of adequate blood 
supply to the fetus.  
The results reviewed here indicate the significance of environmental factors contributing to fetal 
developmental outcome and, subsequently, to the health of an adult. 
It is not yet fully understood how many different mechanisms exist that influence epigenetics 
and, thus, future research should focus on exploring epigenetic regulations, especially in the field 
of placentology, as well as cancer treatments.   
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